EGF and colonic neoplasm: In colon cancer, both Fidarestat and Sorbinil inhibited EGF/FGF-induced growth, migration, and invasion of HT29 and KM20 colon cancer cells, reduced adhesion of tumor cells to growth factor–stimulated endothelial cells and significantly decreased liver metastasis in vivo [52].